Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
5,896
Total Claims
$902K
Drug Cost
459
Beneficiaries
$1,965
Cost/Patient
Risk Score Breakdown 64/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
+1689%
Opioid rate vs peers
67.7% vs 3.8% avg
+67%
Cost per patient vs peers
$1,965 vs $1,174 avg
+77%
Brand preference vs peers
15.7% vs 8.9% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
67.7%
Opioid Rate
3,990
Opioid Claims
$716K
Opioid Cost
30.3%
Long-Acting Rate
This provider's opioid prescribing rate of 67.7% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 925 claims · $666K
Generic: 4,971 claims · $236K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Buprenorphine Hcl | 258 | $229K |
| Oxycodone Myristate | 158 | $135K |
| Buprenorphine | 178 | $72K |
| Tapentadol Hcl | 55 | $52K |
| Tapentadol Hcl | 38 | $40K |
| Oxycodone Hcl | 61 | $38K |
| Hydrocodone/Acetaminophen | 924 | $33K |
| Buprenorphine Hcl/Naloxone Hcl | 84 | $28K |
| Oxycodone Hcl | 764 | $20K |
| Oxycodone Hcl/Acetaminophen | 411 | $17K |
| Erenumab-Aooe | 16 | $16K |
| Hydrocodone Bitartrate | 30 | $15K |
| Semaglutide | 15 | $15K |
| Lidocaine | 15 | $15K |
| Milnacipran Hcl | 12 | $14K |
Prescribing Profile
Patient Profile
68
Avg Age
60%
Female
1.87
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About